Table of Contents Table of Contents
Previous Page  24 / 72 Next Page
Information
Show Menu
Previous Page 24 / 72 Next Page
Page Background

which compose 10% of bone

s organic matrix, also may affect bone

mechanical properties. Osteocalcin stimulates mineral maturation,

inhibits bone formation, recruits osteoclast precursors to bone

resorption sites, and helps with their differentiation into mature

osteoclasts [107]. Osteopontin plays a role in mineralization and assists

the bone resorption process by anchoring osteoclasts to the mineral

matrix of the bone surface [88]. More importantly, these proteins have

been recently considered to act as the glue that holds mineralized

collagen fibers together. When a force is applied, these components

stretch, help dissipate energy by breaking sacrificial bonds between

adjacent collagen fibrils, and prevent harmful crack formation and

propagation [108]. Thus, alterations to the matrix composition of both

collagenous

and

non-collagenous proteins may alter bone biomech-

anical properties. Increased serum osteocalcin and osteopontin has

been reported in postmenopausal womenwith osteoporosis compared

to healthy controls [109,110].

In summary, there is increasing evidence of the role of bone

s

organic matrix on age- and disease-related changes in bone

s

mechanical properties. Enzymatic crosslinking of collagen is generally

considered to have a positive effect on bone

s mechanical properties,

while non-enzymatic crosslinking can lead to deteriorated bone

mechanical properties with aging and disease. Non-collagenous

proteins play a role in the prevention of harmful microdamage

formation. Though osteoporosis is generally defined as a loss of bone

mass, there are considerable matrix changes, particularly in collagen

crosslinks, which cause a loss of bone quality.

Conclusions

The bone

s inorganic and organic composition, its trabecular and

cortical nano-, micro-, and macroscopic architecture, and the hetero-

geneity of these structural features all have impact on age- and disease-

related changes in bone

s mechanical properties. Though osteoporosis

is generally defined as a loss of bone mass, there are considerable

changes of the structure and matrix itself, which can cause a loss of

bone quality.

It is known, that cortical bone plays a major role in determining the

mechanical competence of bone and the risk of fracture; the age-

related alterations of its geometrical features and its local porosity,

though, have long been poorly understood and underestimated. The

number of trabeculae in trabecular bone, trabecular thickness and the

degree of connectivity all influence the mechanical strength of a bone.

In osteoporosis a decrease of all these characteristics is seen. Especially

in bones with increased risk for osteoporotic fractures, however, the

remaining trabecular tissue is largely heterogeneous, with regions of

different mineralization, stiffness and strength.

Both, the trabecular and the cortical component undergo different

changes at different times. Bone remodelling occurs on osseous

surfaces and, thus, osteoporotic bone loss is a function of surface

available for bone remodelling. The bone loss in early osteoporosis is

mainly trabecular and with increasing age the bone loss becomes

primarily endo- and intracortical.

The knowledge about this evolution in matrix and structure in

osteoporotic bone and about the differences between trabecular and

cortical bone could help with predicting, avoiding and treating

osteoporotic fractures. Future clinical imaging techniques will have to

consider structural measures of cortical and trabecular bone rather

than focusing on bone mineral density alone. In prophylactic treatment

regimens, the aimed for therapeutic region (i.e. trabecular versus

cortical) and mechanisms of action within the cascade of bone

remodelling might have to be chosen according to the patient

s age

and the individual advancement of bone changes. Eventually, when a

fracture has occurred, the non-operative or surgical treatment has to

be guided by both: the personality of a patient and the personality of

their bone.

Conflict of interest

The authors report no conflict of interest related to the content of

the manuscript.

References

[1]

Cooper C, Atkinson EJ, O

Fallon WM, Melton LJ, 3rd. Incidence of clinically diagnosed

vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J

Bone Miner Res 1992;7:221

7.

[2]

Schwartz AV, Kelsey JL, Maggi S, Tuttleman M, Ho SC, Jonsson PV, et al. International

variation in the incidence of hip fractures: cross-national project on osteoporosis for

the World Health Organization Program for Research on Aging. Osteoporos Int

1999;9:242

53.

[3]

Tosounidis TH, Castillo R, Kanakaris NK, Giannoudis PV. Common complications in hip

fracture surgery: Tips/tricks and solutions to avoid them. Injury 2015;46(Suppl 5):S3

11.

[4]

Makridis KG, Karachalios T, Kontogeorgakos VA, Badras LS, Malizos KN. The effect of

osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and

mortality in patients with hip fractures: a prospective functional and clinical outcome

study on 520 patients. Injury 2015;46:378

83.

[5]

Guerado E, Cruz E, Cano JR, Crespo PV, Alaminos M, Del Carmen Sánchez-Quevedo M,

Campos A. Bone mineral density aspects in the femoral neck of hip fracture patients.

Injury 2016;47(Suppl 1):S21

4.

[6]

Greenspan SL, Perera S, Nace D, Zukowski KS, Ferchak MA, Lee CJ, et al. FRAX or fiction:

determining optimal screening strategies for treatment of osteoporosis in residents in

long-term care facilities. J Am Geriatr Soc 2012;60:684

90.

[7]

Smith MG, Dunkow P, Lang DM. Treatment of osteoporosis: missed opportunities in the

hospital fracture clinic. Ann R Coll Surg of Engl 2004;86:344

6.

[8]

Kleerekoper M, Nelson DA. Which bone density measurement? J Bone Miner Res

1997;12:712

4.

[9]

Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int 2003;14(Suppl

3):S13

8.

[10]

Nordin M, Frankel VH. Biomechnics of bone. In: Nordin M, Frankel VH, editors. Basic

Biomechanics of the musculoskeletal system. 4th ed. North American: LWW;

2012. p. 472.

[11]

Seeman E, Delmas PD. Bone quality

the material and structural basis of bone strength

and fragility. N Engl J Med 2006;354:2250

61.

[12]

Burstein AH, Reilly DT, Martens M. Aging of bone tissue: mechanical properties. J Bone

Joint Surg Am 1976;58:82

6.

[13]

Carter DR, Hayes WC. Compact bone fatigue damage: a microscopic examination. Clin

Orthop Relat Res 1977:265

74.

[14]

Keaveny TM, Hayes WC. A 20-year perspective on the mechanical properties of

trabecular bone. J Biomech Eng 1993;115:534

42.

[15]

Galante J, Rostoker W, Ray RD. Physical properties of trabecular bone. Calcif Tissue Res

1970;5:236

46.

[16]

Dempster WT, Liddicoat RT. Compact bone as a non-isotropic material. Am J Anat

1952;91:331

62.

[17]

Mittra E, Rubin C, Gruber B, Qin YX. Evaluation of trabecular mechanical and

microstructural properties in human calcaneal bone of advanced age using mechanical

testing, microCT, and DXA. J Biomech 2008;41:368

75.

[18]

Carter DR, Schwab GH, Spengler DM. Tensile fracture of cancellous bone. Acta Orthop

Scand 1980;51:733

41.

[19]

Mizrahi J, Silva MJ, Keaveny TM, Edwards WT, Hayes WC. Finite-element stress analysis

of the normal and osteoporotic lumbar vertebral body. Spine (Phila Pa 1976)

1993;18:2088

96.

[20]

Holzer G, von Skrbensky G, Holzer LA, Pichl W. Hip fractures and the contribution

of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res

2009;24:468

74.

[21]

Gluer CC, Cummings SR, Pressman A, Li J, Gluer K, Faulkner KG, et al. Prediction of hip

fractures from pelvic radiographs: the study of osteoporotic fractures. The Study of

Osteoporotic Fractures Research Group. J Bone Miner Res 1994;9:671

7.

[22]

Hepp P, Theopold J, Osterhoff G, Marquass B, Voigt C, Josten C. Bone quality measured by

the radiogrammetric parameter

cortical index

and reoperations after locking plate

osteosynthesis in patients sustaining proximal humerus fractures. Arch Orthop Trauma

Surg 2009;129:1251

9.

[23]

Zebaze RM, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price RI, et al.

Intracortical remodelling and porosity in the distal radius and post-mortem femurs of

women: a cross-sectional study. Lancet 2010;375:1729

36.

[24]

Svedbom A, Ivergard M, Hernlund E, Rizzoli R, Kanis JA. Epidemiology and economic

burden of osteoporosis in Switzerland. Arch Osteoporos 2014;9:187.

[25]

Edidin AA, Ong KL, Lau E, Kurtz SM. Mortality risk for operated and nonoperated

vertebral fracture patients in the medicare population. J Bone Miner Res

2011;26:1617

26.

[26]

Jacquot F, Letellier T, Atchabahian A, Doursounian L, Feron JM. Balloon reduction and

cement fixation in calcaneal articular fractures: a five-year experience. Int Orthop

2013;37:905

10.

[27]

Osterhoff G, Baumgartner D, Favre P, Wanner GA, Gerber H, Simmen HP, et al. Medial

support by fibula bone graft in angular stable plate fixation of proximal humeral

fractures: an in vitro study with synthetic bone. J Shoulder Elbow Surg 2011;20:740

6.

G. Osterhoff et al. / Injury, Int. J. Care Injured 47S2 (2016) S11

S20

S18